New vaccines for a safer world

CEPI has launched a new call to accelerate COVID-19 vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale.

Find out more

Learn more about COVID-19

The spread of COVID-19 has become a humanitarian and economic crisis. CEPI has moved quickly and urgently to coordinate with global health authorities and partners to rapidly develop vaccine candidates against the disease.

Learn more

We want to create a world in which epidemics are no longer a threat to humanity.

CEPI wants to galvanise the development of new vaccines against diseases we know could cause the next devastating epidemic.

Our approach

$570bn

The estimated annual global cost of moderately severe to severe pandemics

Eleven

The number of diseases WHO identified as public health risks due to epidemic potential and lack of biomedical countermeasures

$2.8bn

The minimum average cost for progressing one vaccine against each of WHO’s 11 priority epidemic infectious diseases

Epidemic diseases affect us all. They do not respect borders.

CEPI (pronounced 'seppy') aims to accelerate the development of vaccines against emerging infectious diseases and enable access to these vaccines for people during outbreaks.

Who we are

Ahmedabad, India (Paula Bronstein/Getty Images Reportage)

Get involved

Our work

Jobs at CEPI

Contact Us

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.